Background: No Covid-19 vaccine has been approved or approved for use in the United States, and the Trump administration and states are still making plans for the rapid distribution of a final vaccine to hundreds of millions of people. The first vaccines are widely expected to reach frontline health care workers and vulnerable populations, including the elderly.
There are some questions about whether Medicare can pay legally for an FDA-approved vaccine on an emergency basis, as the first vaccines can occur. Friday’s announcement along with key drug store chains could potentially address those concerns for residents and employees. in long-term care facilities.
While Trump has repeatedly promised a vaccine available on Election Day, no major pharmaceutical manufacturer plans to submit the vaccine to the FDA for review on November 3. Pfizer CEO Albert Bourla announced on Friday that his The company has no safety data required to submit its vaccine candidate until the end of November. Moderna, another forerunner of the vaccine career, said she was not ready to file an application for permission to use her vaccine before the election.
What̵7;s next: The FDA is scheduled to hold an advisory committee meeting on October 22 to discuss the testing process for a coronavirus vaccine when a company files for approval or approval.